Sensus Healthcare is proud to announce that it has received a Medical Device License from Health Canada, permitting the company to commence selling its advanced SRT-100™ in Canada. The...

Sensus Healthcare is pleased to announce that Froedtert & The Medical College of Wisconsin Cancer Center has chosen the SRT-100™ advanced superficial radiotherapy platform (SRT) as the latest...

Sensus Healthcare is pleased to announce the acceptance and publication of the most comprehensive study to date on treating Non Melanoma Skin Cancer (NMSC) with superficial radiotherapy (SRT) in...

Sensus Healthcare is pleased to announce its exhibitor participation in the 54th Annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, MA on October 28 -...

Sensus Healthcare is proud to announce a major milestone in selling its 100th SRT-100™ advanced superficial radiotherapy (SRT) system. The SRT-100™ is a global success for treating Non...